Both in Pharmaceuticals
CervoMed vs Celularity
Over the past year CRVO returned −77.2% and CELU returned −53.5%; their daily moves had a correlation of 0.06.
CRVO −77.2% CELU −53.5%Growth of $1, one year, split-adjusted
| Metric | CRVO | CELU |
|---|---|---|
| Price | $1.60 | $0.8001 |
| Market cap | $24.2M | $26.0M |
| Today | −8.57% | −5.79% |
| 1 month | −45.4% | −42.0% |
| 6 months | −56.9% | −16.4% |
| Year to date | −79.7% | −27.9% |
| 1 year | −76.7% | −58.5% |
| Revenue growth (YoY) | −100.0% | −5.3% |
| Gross margin | — | 56.8% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | 73.0× | 1.4× |
| Net cash | $24.9M | -$37.1M |
| Dividend yield | — | — |
| Volatility (60d) | 90.0% | 223.2% |
| Short % of float | 12.7% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).